AFC
TMO icon

Ares Financial Consulting’s Thermo Fisher Scientific TMO Stock Holding History

Ares Financial Consulting’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$124K Buy
248
+9
+4% +$4.32K 0.09% 123
2026
Q1 		$118K Buy
239
+144
+152% +$78.1K 0.09% 111
2025
Q4 		$55K Buy
+95
New +$53.7K 0.05% 153

Other funds holding TMO

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Ares Financial Consulting's TMO Position: Q2 2026 in Review

Ares Financial Consulting increased its Thermo Fisher Scientific (TMO) stake by 3.8% in Q2 2026, buying an estimated $4.32K and bringing the position to 248 shares worth $124K. The position accounts for 0.09% of the portfolio, ranked #123.

Ares Financial Consulting first reported a position in TMO in Q4 2025 and has held it in 3 quarters since. 1,415 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Ares Financial Consulting held 248 shares of Thermo Fisher Scientific worth $124K as of Q2 2026.
  • Ares Financial Consulting bought 9 Thermo Fisher Scientific shares in Q2 2026, an estimated $4.32K.
  • Thermo Fisher Scientific made up 0.09% of Ares Financial Consulting's portfolio in Q2 2026, its #123 holding.
  • Ares Financial Consulting first reported a position in Thermo Fisher Scientific in Q4 2025 and has held it in 3 quarters since.
  • 1,415 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.